论文部分内容阅读
选用健康成年昆明种小白鼠１５０ 只，雌雄各半，设利脑康高、中、低三个剂量组，空白对照组和脑复康阳性对照组共５ 组，药效学研究结果显示，利脑康高剂量组能明显延长全脑缺血的存活时间（１２．１±４．６ｖｓ 对照４．３±２．９ｍ ｉｎ，Ｐ＜ ０．０１）；高、中剂量组均能提高小鼠抗疲劳的能力（１５．１±４．１，１１．２±３．１ｖｓ 对照７．４±３．５ｍ ｉｎ，Ｐ＜ ０．０１，Ｐ＜ ０．０５）；还有明显促进睡眠的作用（中剂量组，Ｐ＝ ０．００７；高剂量组，Ｐ＝ ０．００２）。以上实验结果为本品的临床应用提供了药理学依据。
One hundred and fifty healthy adult Kunming mice were selected, half male and half female. Three doses of high-, medium-, and low-dose Lilinkang were set up. Five groups were included in the blank control group and Naofukang positive control group. Pharmacodynamic studies showed that Li The high dose of Naokang significantly prolonged the survival time of global cerebral ischemia (12.1±4.6vs, control, 4.3±2.9 in, P<0.01); both high and middle dose groups can increase mice Anti-fatigue abilities (15.1±4.1, 11.2±3.1 vs controls 7.4±3.5 m in, P<0.01, P<0.05); (medium dose group, P = 0.007; high dose group, P = 0.002). The above experimental results provide pharmacological basis for the clinical application of this product.